Lung Cancer Research Foundation (LCRF): Research Award on Innovative Therapeutic Strategies to Treat ALK Positive Lung Cancers

Work supported through this mechanism will address important mechanistic questions and developmental therapeutics across the care continuum and has the potential to increase survivorship. Given the specific interest in the development of novel therapies that could benefit this group of patients in the relatively near-term, a clinical trial must be associated with the project. Funding: up to $2M, over 3 years. (Non-profit) 

https://www.lungcancerresearchfoundation.org/research/funding-opportunities-2023/